Shuai Li | Biology and Life Sciences | Innovative Research Award

Innovative Research Award

Shuai Li
Regeneron, United States
Shuai Li
Affiliation Regeneron
Country United States
Scopus ID 60597499200
Documents 6
Citations 221
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1537-3956

The Innovative Research Award recognizes the scholarly and scientific contributions of Shuai Li, a researcher associated with Regeneron and previously affiliated with Duke University. Li has contributed to interdisciplinary research spanning synthetic biology, metabolic engineering, supramolecular chemistry, and automated bioprocess technologies. The research portfolio demonstrates a combination of experimental innovation, engineering methodology, and translational biological applications within the broader field of biology and life sciences.[1]

Abstract

Shuai Li has developed a multidisciplinary academic profile integrating biological engineering, synthetic biology, supramolecular chemistry, and automation systems for laboratory applications. Published works include contributions to metabolic engineering in Escherichia coli, chiral molecular assemblies, CRISPR-associated biological systems, and open-source laboratory automation. The body of work reflects ongoing efforts to optimize biological production systems, enhance molecular recognition strategies, and improve accessibility to bioprocess instrumentation.[2][3]

Keywords

Synthetic Biology; Metabolic Engineering; Bioprocess Automation; Supramolecular Chemistry; CRISPR Systems; NADPH Flux; Chiroptical Switches; Biological Engineering; Automated Sampling Systems; Life Sciences Research.

Introduction

Contemporary life sciences research increasingly depends upon interdisciplinary approaches that integrate chemistry, engineering, automation, and computationally informed biological experimentation. Shuai Li’s scholarly contributions reflect this evolving research landscape through work involving engineered microbial systems, supramolecular interfaces, and laboratory automation platforms.[4]

Li completed academic training at Shandong University and the Institute of Chemistry of the Chinese Academy of Sciences before continuing research activities at Duke University. These educational and research experiences contributed to a broad methodological background that spans chemical sciences and biotechnology-oriented engineering disciplines.[1]

Research Profile

The Scopus author profile associated with Shuai Li reports 221 citations across multiple indexed documents and an h-index of 4, indicating measurable academic engagement and scholarly visibility within biotechnology and chemistry-related research communities.[1]

Research topics explored by Li include metabolic pathway optimization, enzyme regulation, supramolecular assembly, CRISPR/Cas systems, and automated sampling technologies for bioreactors. Publications demonstrate collaborations across academic laboratories and interdisciplinary scientific environments.[5]

  • Research specialization in synthetic biology and metabolic engineering.
  • Contributions to supramolecular and chiral chemistry methodologies.
  • Development of low-cost automated laboratory technologies.

Research Contributions

Among Li’s notable contributions is the development of the BioSamplr, an open-source automated sampling system designed for bioreactors. The platform aimed to provide a lower-cost alternative for laboratory sampling automation, thereby increasing accessibility for smaller research laboratories and educational institutions.[2]

Li also contributed to research focused on improving NADPH flux and xylitol biosynthesis in engineered E. coli systems through dynamic regulatory control strategies. This work addressed feedback regulation mechanisms and metabolic optimization relevant to industrial biotechnology applications.[3]

Additional studies investigated CRISPR-associated endonuclease complexes and their effects on self-targeting spacer stability. These findings contributed to understanding microbial genome regulation and CRISPR system functionality.[6]

In the field of supramolecular chemistry, Li co-authored studies examining chiroptical switches, chiral metallogels, and self-assembled polydiacetylene systems for enantioselective recognition. These works demonstrated applications of molecular self-assembly and chirality transfer in advanced chemical systems.[7][8]

Publications

  1. BioSamplr: An open source, low cost automated sampling system for bioreactors — HardwareX (2021).
  2. Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli — Metabolic Engineering (2021).
  3. Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability — ACS Synthetic Biology (2020).
  4. Supramolecular chiroptical switches — Chemical Society Reviews (2020).
  5. Self-Assembled Polydiacetylene Vesicle and Helix with Chiral Interface for Visualized Enantioselective Recognition of Sulfinamide — ACS Applied Materials & Interfaces (2017).

Research Impact

The academic impact of Li’s work is reflected through citations, interdisciplinary collaborations, and publication in peer-reviewed journals covering biotechnology, synthetic biology, materials science, and supramolecular chemistry. Research outputs have relevance for both academic investigation and industrial biotechnology applications.[3][7]

The integration of engineering principles with biological systems research has contributed to emerging methodologies in automated experimentation and metabolic pathway optimization. Such interdisciplinary work supports broader scientific efforts aimed at improving efficiency, reproducibility, and accessibility in laboratory research environments.[2]

Award Suitability

Shuai Li’s multidisciplinary research background aligns with the objectives of the Global Innovation Technologist Awards, which recognize scientific and technological advancements with measurable academic and practical significance. Contributions spanning metabolic engineering, CRISPR research, supramolecular chemistry, and open-source automation technologies demonstrate consistent engagement with innovation-oriented scientific inquiry.[1]

The combination of peer-reviewed publications, measurable citation performance, and interdisciplinary technical expertise supports recognition within the field of biology and life sciences. Li’s work illustrates the integration of engineering design principles with biological and chemical sciences to address contemporary research challenges.[4]

Conclusion

The scholarly profile of Shuai Li reflects interdisciplinary scientific engagement across synthetic biology, supramolecular chemistry, and laboratory engineering technologies. Through publications in recognized journals and contributions to biological automation systems, Li has participated in research initiatives with relevance to modern biotechnology and life sciences. The body of work demonstrates methodological diversity, collaborative scientific activity, and continuing participation in innovation-oriented academic research.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Shuai Li, Author ID 60597499200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60597499200
  2. Li, S. et al. (2021). BioSamplr: An open source, low cost automated sampling system for bioreactors. HardwareX.
    https://doi.org/10.1016/j.ohx.2021.e00177
  3. Li, S. et al. (2021). Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli. Metabolic Engineering.
    https://doi.org/10.1016/j.ymben.2021.01.005
  4. ORCID. (n.d.). Shuai Li ORCID profile and educational background.
    https://orcid.org/0000-0002-1537-3956
  5. Crossref Metadata Search. (n.d.). Publication metadata associated with Shuai Li.
  6. Li, S. et al. (2020). Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability. ACS Synthetic Biology.
    https://doi.org/10.1021/acssynbio.0c00398
  7. Li, S. et al. (2020). Supramolecular chiroptical switches. Chemical Society Reviews.
    https://doi.org/10.1039/d0cs00191k
  8. Li, S. et al. (2017). Alanine-Based Chiral Metallogels via Supramolecular Coordination Complex Platforms: Metallogelation Induced Chirality Transfer. Journal of the American Chemical Society.
    https://doi.org/10.1021/jacs.7b10769

Liang Yang | Life Sciences | Research Excellence Award

Assoc. Prof. Dr. Liang Yang | Life Sciences | Research Excellence Award

Associate Researcher | Guangzhou Institute of Biomedicine and Health | China

Liang Yang is an associate-level researcher at the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, specializing in mitochondrial biology with a focus on development, aging, and disease. His work has revealed novel mechanisms of mitochondrial DNA translation, quality control, and redox regulation, with major contributions to understanding early development, intestinal and reproductive aging, and cancer metabolism. He has published extensively in leading journals such as Cell Metabolism, Nature Communications, Science Bulletin, and Aging Cell, and his research integrates basic discovery with translational and technological innovation in mitochondrial science.

Citation Metrics (Scopus)

1200

900

600

300

0

Citations
1,194

Documents
27

h-index
18

                     🟦 Citations       🟥 Documents       🟩 h-index


View Scopus Profile

Featured Publications

Metabolic Reprogramming Regulates Cell Fate Transition during Somatic Cell Reprogramming

– Cell Metabolism

Mitochondrial Dynamics and Epigenetic Regulation in Pluripotent Stem Cells

– Nature Communications

Coordination of Mitochondrial Metabolism and Nuclear Reprogramming during Induced Pluripotent Stem Cell Generation

– EMBO Journal

Sara Carloni | Biology and Life Sciences | Best Researcher Award

Assist. Prof. Dr. Sara Carloni | Biology and Life Sciences | Best Researcher Award

Assistant Professor at Humanitas University, Italy

Dr. Sara Carloni is an Assistant Professor of Microbiology and Clinical Microbiology at Humanitas University, Italy. Her career spans over a decade of cutting-edge research into microbial pathogenesis, microbiota-host interactions, the gut-brain axis, and antimicrobial resistance (AMR). A pivotal figure in translational microbiology, Dr. Carloni has contributed substantially to both experimental and clinical microbiology. Her breakthrough discovery of a choroid plexus vascular barrier associated with intestinal inflammation, published in Science (2021), has positioned her as a global leader in microbiota and neuroinflammation studies. As a corresponding or leading author on multiple high-impact publications and a frequent speaker at international conferences, she continues to influence the future of biomedical sciences.

Publication Profile 

Scopus

Orcid

Educational Background 🎓

Dr. Sara Carloni has cultivated a robust academic foundation in microbiology and biotechnology through progressive and interdisciplinary training across prestigious institutions. She earned her Bachelor’s degree in Industrial and Environmental Biotechnologies in 2009 from a joint program between Università degli Studi di Milano and Universitat Rovira i Virgili in Spain. She then completed her Master’s degree in Biotechnology at Università degli Studi di Milano in July 2011. Driven by a keen interest in microbial research, she pursued a Ph.D. in Biological and Molecular Sciences with a specialization in Molecular Microbiology, which she completed in May 2015 at Università degli Studi di Milano. Following her doctorate, she engaged in several postdoctoral fellowships: first at Università degli Studi di Milano (2015), focusing on small RNA-mediated mechanisms in Pseudomonas aeruginosa; then at the European Institute of Oncology (2016–2017), investigating microbiota in intestinal and oncologic disorders; and subsequently at Humanitas University (2018–2021), where she delved into the gut-brain axis and intestinal inflammation. Her academic journey culminated in her appointment as Assistant Professor of Microbiology and Clinical Microbiology (RTDA) at Humanitas University in 2021.

Professional Experience 💼

  • Assistant Professor (RTDA)
    Humanitas University (2021–Present)

    • Teaching and research in Microbiology and Clinical Microbiology (MED/07)

    • Supervising PhD and MD students; leading microbiota and AMR research units

  • Postdoctoral Fellow
    Humanitas University (2018–2021)

    • Investigated gut-brain axis, choroid plexus, and intestinal inflammation

  • Postdoctoral Fellow
    European Institute of Oncology (IEO) (2016–2017)

    • Microbiota in IBD and tumorigenesis; explored colitis-brain interaction

  • Postdoctoral Fellow
    Università degli Studi di Milano (2015)

    • Studied quorum sensing and small RNAs in Pseudomonas aeruginosa

Research Interests 🔬

  • Gut-Brain Axis (GBA) and Vascular Barriers

  • Antimicrobial Resistance (AMR)

  • Host-Microbiota Interactions

  • Microbial Metabolites and Neuroinflammation

  • Translational Microbiology

  • Bacterial Extracellular Vesicles (bEVs)

  • Artificial Intelligence in Microbial Diagnostics

Awards and Honors🏆✨

  • Invited Speaker at premier international conferences including:

    • Digestive Disease Week (2024)

    • ECCO Congress (2024)

    • Potsdam Symposium on Mucosal Immunology (2023)

    • IFHNOS World Congress Moderator (2023)

  • Leader of research units in:

    • PNRR-INF-ACT (One Health & AMR Surveillance)

    • PNRR-NBFC (Human Wellbeing & Microbial Biodiversity)

    • 5X1000 Humanitas (IBD and Psychiatric Comorbidities)

  • Visiting Professor, Institut Pasteur – Leadership in microbiota-host interaction and bEVs research

Conclusion🌟

Dr. Sara Carloni stands out as an innovative and collaborative microbiologist, contributing significantly to modern biomedical research. With over 19 peer-reviewed publications, an H-index of 11, and over 1200 citations, she merges basic science discoveries with clinical applications, particularly in AMR surveillance and gut-brain communication. Her multidisciplinary and translational approach places her at the forefront of microbiology, making her a strong contender for high-level research recognitions and global scientific leadership.

Publications 📚

  1. 🍼 Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome
    🗞 Nature Communications
    📅 2025-05-09 | 🔗 DOI: 10.1038/s41467-025-58533-8
    👩‍🔬 Contributors: Silvia Giugliano, Andrea Gatti, Martina Rusin, Tilo Schorn, Silvia Pimazzoni, Michela Calanni-Pileri, Valentina Fraccascia, Sara Carloni, Maria Rescigno


  2. 🧫 Epidemiology and resistance profiles of bacteria isolated from blood samples in septic patients at emergency department admission: A 6-year single-centre retrospective analysis from Northern Italy
    🗞 Journal of Global Antimicrobial Resistance
    📅 2025-03 | 🔗 DOI: 10.1016/j.jgar.2024.12.023
    👩‍🔬 Contributors: Valeria Cento, Sara Carloni, Riccardo Sarti, et al.


  3. 🤰 Role of the maternal gut microbiota in immune activation at the maternal-fetal interface: Impact on preeclampsia
    📄 Preprint
    📅 2023-05-30 | 🔗 DOI: 10.21203/rs.3.rs-2845955/v1
    👩‍🔬 Contributors: Maria Rescigno, Silvia Giugliano, Sara Carloni, Tilo Schorn


  4. 🧠 Unveiling the gut-brain axis: Structural and functional analogies between the gut and the choroid plexus vascular and immune barriers
    🗞 Seminars in Immunopathology
    🔗 DOI: 10.1007/S00281-022-00955-3
    👩‍🔬 Contributors: Sara Carloni, Maria Rescigno


  5. 🦠 Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
    🗞 Cancer Cell
    🔗 DOI: 10.1016/j.ccell.2021.03.004
    👩‍🔬 Contributors: Bertocchi, A., Carloni, S., et al.


  6. 🧠 Identification of a choroid plexus vascular barrier closing during intestinal inflammation
    🗞 Science
    🔗 DOI: 10.1126/science.abc6108
    👩‍🔬 Contributors: Carloni, S., Bertocchi, A., et al.


  7. 🧪 SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
    🗞 Scientific Reports
    🔗 DOI: 10.1038/s41598-021-91773-4
    👩‍🔬 Contributors: Sandri, M.T., Carloni, S., et al.


  8. 🧫 Complement C3aR loss drives colorectal cancer by modulating gut microbiota
    🗞 Journal of Immunology
    🔗 WOS: WOS:000589972400485
    👩‍🔬 Contributors: Guglietta, Silvia, Carloni, Sara, et al.


  9. 🦠 Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth
    🗞 Nature Microbiology
    🔗 DOI: 10.1038/s41564-019-0649-5
    👩‍🔬 Contributors: Zagato, E., Carloni, S., et al.


  10. 🧪 IgG serology in health care and administrative staff populations from 7 hospitals representative of different exposures to SARS-CoV-2 in Lombardy, Italy
    📄 medRxiv Preprint
    🔗 DOI: 10.1101/2020.05.24.20111245
    👩‍🔬 Contributors: Sandri, M.T., Carloni, S., et al.


  11. 💩 Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
    🗞 Nature Communications
    🔗 DOI: 10.1038/s41467-018-07359-8
    👩‍🔬 Contributors: Burrello, C., Carloni, S., et al.


  12. 🧬 The small RNA ReaL: A novel regulatory element embedded in the Pseudomonas aeruginosa quorum sensing networks
    🗞 Environmental Microbiology
    🔗 DOI: 10.1111/1462-2920.13886
    👩‍🔬 Contributors: Carloni, S., Macchi, R., et al.


  13. 🦠 Post-transcriptional regulation of the virulence-associated enzyme AlgC by the σ²²-dependent small RNA ErsA of Pseudomonas aeruginosa
    🗞 Environmental Microbiology
    🔗 DOI: 10.1111/1462-2920.12590
    👩‍🔬 Contributors: Ferrara, S., Carloni, S., et al.